IL10 and head and neck squamous cell carcinoma: Further, in HNSCC patients successfully treated with chemoradiotherapy (CRT) and evaluated during post-therapy clinical remission, only CD39+, but not IL-10+ or TGF-β+ Treg, were found to be expanded and to accumulate.